Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Atherosclerosis. 2022 Nov 12;363:8–21. doi: 10.1016/j.atherosclerosis.2022.11.009

Figure 4.

Figure 4.

INOCA anti-anginal management strategies.

INOCA patients have a variable response to traditional anti-anginal therapies. Optimal medical therapy with statins, ACE-I, and Aspirin as anti-atherosclerotic medications are used in INOCA, and the results of the WARRIOR trial are pending.